早期 (T1) 阴茎癌生存率的种族差异:来自SEER数据库的分析
Nellowe C Candelario1, Elizabeth Molina1, Maria T Bourlon2
1Division of Medical Oncology, University of Colorado Cancer Center Anschutz Medical Campus, Aurora, CO.
Urologic oncology
|June 21, 2023
概括
种族差异影响早期阴茎癌患者的生存率. 与白人男性相比,患有T1阴茎癌的西班牙裔男性的癌症特异性生存率 (CSS) 较差,这凸显了针对性干预的需要.
科学领域:
- 在瘤学瘤学.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 健康差距 研究 研究 研究 研究
背景情况:
- 阴茎癌很罕见,占美国男性癌症的不到1%.
- 早期阶段 (T1) 阴茎癌可能可以通过局部疗法治愈.
- 了解生存结果的种族差异对于公平的护理至关重要.
研究的目的:
- 调查T1阴茎癌癌症癌症特异性生存率 (CSS) 的种族差异.
- 分析影响早期阴茎癌患者CSS的预后变量.
主要方法:
- 利用了SEER-18数据库 (2004-2016) 的数据,用于患有T1,N0,M0阴茎癌的男性.
- 使用Kaplan-Meier分析来评估生存率.
- 进行多变量考克斯回归分析以确定独立的预后因素.
主要成果:
- 总共有1941名患有T1阴茎癌的男性被分析.
- 主要部位手术显著改善了5年的CSS (P <.0001).
- 与白人男性相比,西班牙裔男性的CSS明显差 (HR 1.92;P=.0057);黑人男性的CSS明显差 (HR 1.53;P=.118) 的趋势并不显著.
- 阴茎切除术 (HR 0.45;P=.006) 和阴茎保护手术 (HR 0.25;P<0.001) 都改善了CSS.
结论:
- 对于早期的阴茎癌,CSS存在显著的种族差异.
- 与白人种族相比,西班牙裔种族与更糟糕的CSS有关.
- 在主要部位进行手术干预可以改善T1阴茎癌的生存结果.
相关概念视频
Cancer Survival Analysis
402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402
Comparing the Survival Analysis of Two or More Groups
228
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
228
Actuarial Approach
99
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
99
Survival Curves
217
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
217
Assumptions of Survival Analysis
160
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
160
Kaplan-Meier Approach
195
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
195


